Acquisitions (Tables)

0 Months Ended

Jan. 14, 2011

Arresto Biosciences, Inc. [Member]

Apr. 02, 2011

Calistoga Pharmaceuticals, Inc. [Member]

Business Acquisition [Line Items]

Fair Values Of The Assets Acquired And Liabilities Assumed

IPR&D	$	117,000
Goodwill		134,482
Deferred tax assets		17,417
Deferred tax liabilities		(41,705	)
Other net liabilities assumed		(125	)
Total consideration transferred	$	227,069

IPR&D	$	149,200
Goodwill		336,951
Other net liabilities assumed		(1,853	)
Total consideration transferred	$	484,298